[Is there progress in the chemotherapy of small cell lung cancer?].
Small cell lung cancer (SCLC) is a frequent neoplastic disease which has shown an increasing incidence during recent years, particularly in women. Because of the high sensitivity of chemotherapy, remission is usually achieved with standard regimens. However, relapses are common and 5-year survival is < 10%. Over the last few years intensive chemotherapy with or without stem cell support has been developed and has brought about an improvement of overall survival in SCLC patients. This therapeutic approach is reviewed.
Calderoni
A
A
Institut für Medizinische Onkologie, Inselspital, Universität Bern. antonello.calderoni@insel.ch
Cerny
T
T
Betticher
D C
DC
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D004358:Drug Therapy / Q000639:trends; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D008297:Male; D016019:Survival Analysis
D000970:Antineoplastic Agents